EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures
17 May 2016 | By Katie Sadler
The European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.